Class II
Terminated
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
Why: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
- Company
- CARDINAL HEALTHCARE
Dublin, OH, United States - Reported
- Jan 3, 2024
- Recall started
- Jan 26, 2022
- Ended
- Sep 29, 2024
- Where sold
- Nationwide USA
- Amount
- 1 unit
- Full product description
- Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
- Lots / codes affected
- Batch 3138326
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.